Cancer Family
Gastric Neoplasm
CI-CAN-00000185Explore in graph →
Non-malignant720 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000185Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01917552 | Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer((KCSG ST14-05): CATALYSIS | unknown | Phase 3 | 870 | Asan Medical CenterOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT04714190 | A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression | unknown | Phase 3 | 351 | RemeGen Co., Ltd.INDUSTRY | 1 | Dec 21, 2023 | clinicaltrials |
| NCT04219332 |
| Randomized Controlled Trial on Effect of Lymph Node Mapping by Indocyanine Green Via Submucosal or Subserosal Injection |
| unknown |
| Phase 3 |
| 266 |
| Fujian Medical UniversityOTHER |
| 1 |
| Oct 10, 2023 |
| clinicaltrials |
| NCT02338518 | Comparison of SEEOX and SOX Regimens in Stage ⅢB/ⅢC Gastric Cancer Patients(SVOSA) | unknown | Phase 3 | 297 | Jinling Hospital, ChinaOTHER | 1 | Sep 29, 2023 | clinicaltrials |
| NCT05325528 | Study of Tislelizumab in Combination With SOX for the Treatment of Gastric Cancer With Liver Metastases | unknown | Phase 2 / Phase 3 | 40 | Zhejiang UniversityOTHER | 1 | Feb 1, 2023 | clinicaltrials |
| NCT04222114 | Comparing the Efficacy and Safety of Intra-peritoneal Infusion of Catumaxomab and Treatment of Investigator Choice in Patients With Advanced Gastric Carcinoma With Peritoneal Metastasis | unknown | Phase 3 | 282 | LintonPharm Co.,Ltd.INDUSTRY | 3 | Jan 31, 2023 | clinicaltrials |
| NCT04139135 | A Clinical Study of HLX10 Combined With Chemotherapy Versus Placebo Combined With Chemotherapy for Neoadjuvant/Adjuvant Treatment of Gastric Cancer | unknown | Phase 3 | 642 | Shanghai Henlius BiotechINDUSTRY | 1 | Jun 6, 2022 | clinicaltrials |
| NCT03801668 | Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric Adenocarcinoma | unknown | Phase 3 | 294 | Huazhong University of Science and TechnologyOTHER | 1 | Jan 4, 2022 | clinicaltrials |
| NCT02934464 | Assessment of Ramucirumab Plus Paclitaxel as Switch MANteInance Versus Continuation of First-line Chemotherapy in Patients With Advanced HER-2 Negative Gastric or Gastroesophageal Junction Cancers(ARMANI) | unknown | Phase 3 | 280 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Sep 13, 2021 | clinicaltrials |
| NCT05002686 | Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node Metastasis | unknown | Phase 2 / Phase 3 | 60 | Ruijin HospitalOTHER | 1 | Aug 24, 2021 | clinicaltrials |
| NCT04358354 | Triplet Combination of Cytotoxics as First-line Treatment for Metastatic Gastric Cancer | unknown | Phase 3 | 388 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Jul 19, 2021 | clinicaltrials |
| NCT03961867 | Docetaxel Versus Oxaliplatin as Addition to S-1 for Stage II / III Gastric Adenocarcinoma | unknown | Phase 3 | 440 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Jun 1, 2021 | clinicaltrials |
| NCT04393584 | FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma(RusGCG-01) | unknown | Phase 2 / Phase 3 | 538 | Blokhin's Russian Cancer Research CenterOTHER | 1 | Apr 13, 2021 | clinicaltrials |
| NCT04486651 | HX008 Plus Irinotecan Versus Placebo Plus Irinotecan as Second-line Treatment in Advanced Gastric Cancer | unknown | Phase 3 | 560 | Taizhou Hanzhong biomedical co. LTDINDUSTRY | 1 | Jan 28, 2021 | clinicaltrials |
| NCT04351867 | A Clinical Trial of Two Adjuvant Chemotherapy Regimens for Postoperative Gastric Cancer | unknown | Phase 3 | 196 | LiNingOTHER_GOV | 1 | Jul 16, 2020 | clinicaltrials |
| NCT03160924 | The Impact of Enhanced Recovery After Surgery (ERAS) Program on Clinical and Immunological Outcomes for Minimally-invasive Gastrectomy | unknown | Phase 3 | 50 | Chinese University of Hong KongOTHER | 1 | May 22, 2020 | clinicaltrials |
| NCT03817268 | Capecitabine or Observation for Patients With pT1N+M0 or pT2-3N0M0 Gastric Adenocarcinoma Undergoing R0 Resection(CAPOGA) | unknown | Phase 3 | 768 | The First Affiliated Hospital of Anhui Medical UniversityOTHER | 1 | Apr 20, 2020 | clinicaltrials |
| NCT01761461 | Phase III Randomized Trial of Adjuvant Chemotherapy With S-1 vs S-1/Oxaliplatin ± Radiotherapy for Completely Resected Gastric Adenocarcinoma : The ARTIST II Trial(ARTIST-II) | unknown | Phase 3 | 547 | Samsung Medical CenterOTHER | 1 | Mar 25, 2020 | clinicaltrials |
| NCT04135781 | Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric Cancer | unknown | Phase 3 | 616 | Zhejiang Cancer HospitalOTHER | 1 | Mar 23, 2020 | clinicaltrials |
| NCT03264807 | Lymph Node 14v Dissection in Clinical Stage T3N+, T4N+ of Gastric Cancer | unknown | Phase 3 | 518 | National Cancer Center, KoreaOTHER_GOV | 1 | Mar 3, 2020 | clinicaltrials |
| NCT03788226 | A Randomized Phase III Study Comparing POF With SOX/CAPOX/FOLFOX as a Postoperative Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer | unknown | Phase 3 | 600 | Fujian Cancer HospitalOTHER_GOV | 1 | Oct 16, 2019 | clinicaltrials |
| NCT03023436 | Cytoreductive Surgery Combined With HIPEC and Chemotherapy for Gastric Cancer With Peritoneal Metastasis | unknown | Phase 3 | 220 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Sep 13, 2019 | clinicaltrials |
| NCT03654534 | Oral Nutritional Supplements Compared With Standard Diet in Postoperative Gastric Cancer Patients With Adjuvant Chemotherapy | unknown | Phase 3 | 374 | Sun Yat-sen UniversityOTHER | 1 | Apr 17, 2019 | clinicaltrials |
| NCT03889626 | The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer | unknown | Phase 3 | 242 | Fudan UniversityOTHER | 0 | Mar 26, 2019 | clinicaltrials |
| NCT03680261 | Enriched-CRT 2017: Advanced Gastric Cancer With LN+ and LVI+, Chemotherapy vs. Chemoradiotherapy | unknown | Phase 3 | 556 | Shanghai Zhongshan HospitalOTHER | 1 | Sep 21, 2018 | clinicaltrials |
| NCT03598348 | Evaluate the Efficacy of Maintenance Treatment With Capecitabine Plus Apatinib in Advanced Gastric Cancer | unknown | Phase 3 | 288 | Huazhong University of Science and TechnologyOTHER | 1 | Jul 26, 2018 | clinicaltrials |
| NCT03601988 | Phase III Trial of Adjuvant Chemo-radiotherapy After D2 Surgery of Gastric Cancer | unknown | Phase 3 | 408 | Huazhong University of Science and TechnologyOTHER | 1 | Jul 26, 2018 | clinicaltrials |
| NCT03475615 | A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites | unknown | Phase 3 | 215 | Fudan UniversityOTHER | 1 | Mar 23, 2018 | clinicaltrials |
| NCT02110628 | Roux-en-Y vs. Roux-en-Y+ Pouch for D2 Total Gastrectomy(WCGCC-1202) | unknown | Phase 3 | 588 | West China HospitalOTHER | 1 | Jan 24, 2018 | clinicaltrials |
| NCT03399253 | Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor | unknown | Phase 2 / Phase 3 | 120 | Sun Yat-sen UniversityOTHER | 1 | Jan 16, 2018 | clinicaltrials |
| NCT02461407 | Study of Anlotinib in Patients With Gastric Cancer(ALTER0503) | unknown | Phase 2 / Phase 3 | 378 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Dec 29, 2017 | clinicaltrials |
| NCT03355612 | XELOX Plus Apatinib vs XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring Carcinoma | unknown | Phase 3 | 456 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Nov 28, 2017 | clinicaltrials |
| NCT02356276 | Efficacy of HIPEC in the Treatment of Locally Advanced Gastric Cancer After radIcal Gastrectomy With D2(EHTLAGCRGD2) | unknown | Phase 3 | 584 | Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityOTHER | 1 | Oct 31, 2017 | clinicaltrials |
| NCT00407186 | Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer (CRITICS) | unknown | Phase 3 | 788 | Dutch Colorectal Cancer GroupOTHER | 1 | Oct 10, 2017 | clinicaltrials |
| NCT02509806 | Apatinib as Maintenance Therapy After First-line Chemotherapy(DC for 4 Cycles) in Postoperative Recurrence/Metastasis Progressive Gastric Cancer | unknown | Phase 2 / Phase 3 | 48 | Hebei Medical UniversityOTHER | 1 | Oct 9, 2017 | clinicaltrials |
| NCT02510469 | Apatinib as Maintenance Therapy After Adjuvant Chemotherapy in Progressive Gastric Cancer With Positive Exfoliative Cancer Cells | unknown | Phase 2 / Phase 3 | 48 | Hebei Medical UniversityOTHER | 1 | Oct 9, 2017 | clinicaltrials |
| NCT03061058 | Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for AGC | unknown | Phase 3 | 240 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Sep 15, 2017 | clinicaltrials |
| NCT03223740 | Preoperative Stomach Cancer Induction Chemotherapy and Radiation Therapy(President) | unknown | Phase 3 | 450 | Sichuan Provincial People's HospitalOTHER | 1 | Aug 21, 2017 | clinicaltrials |
| NCT02289547 | Phase 3 Study of Xelox Followed by Maintenance Capecitabine in the Advanced Gastric Cancer | unknown | Phase 3 | 184 | The Catholic University of KoreaOTHER | 1 | Jun 14, 2017 | clinicaltrials |
| NCT03179579 | Efficacy of HIPEC Combined With Systemic Chemotherapy and CRS on Peritoneal Metastases From Gastric Cancer | unknown | Phase 3 | 88 | Shu-Zhong CuiOTHER | 1 | Jun 7, 2017 | clinicaltrials |
| NCT03015675 | IV Ascorbic Acid in Advanced Gastric Cancer | unknown | Phase 3 | 200 | Sun Yat-sen UniversityOTHER | 1 | May 18, 2017 | clinicaltrials |
| NCT03117023 | The Addition of Dexmedetomidine on Postoperative Sleep for Middle-aged and Elderly Patients With Gastric Cancer | unknown | Phase 3 | 50 | Nanjing PLA General HospitalOTHER | 0 | Apr 17, 2017 | clinicaltrials |
| NCT02780921 | Effect of Prehabilitation in Gastroesophageal Adenocarcinoma: Study Protocol of a Multicentric, Randomised Control Trial(PREHAB) | unknown | Phase 3 | 120 | University Hospital, Clermont-FerrandOTHER | 1 | Jan 25, 2017 | clinicaltrials |
| NCT02748551 | A Comparison Laparoscopic With Open Gastric Cancer Surgery for Locally Advanced Gastric Cancer | unknown | Phase 3 | 800 | Moscow Clinical Scientific CenterOTHER | 2 | Dec 13, 2016 | clinicaltrials |
| NCT02980861 | Laparoscopic Versus Open Gastrectomy With Splenic Hilum Lymph Nodes Dissection | unknown | Phase 3 | 200 | Chinese PLA General HospitalOTHER | 1 | Dec 6, 2016 | clinicaltrials |
| NCT01795027 | Compare S-1 Plus Oxaliplatin to S-1 as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer(CAPITAL) | unknown | Phase 3 | 724 | Sun Yat-sen UniversityOTHER | 1 | Oct 25, 2016 | clinicaltrials |
| NCT01911832 | Impact of Gastric Tube Reconstruction Widths on Quality of Life for Esophagogastric Cancers | unknown | Phase 3 | 60 | West China HospitalOTHER | 1 | Sep 13, 2016 | clinicaltrials |
| NCT02537171 | Apatinib as Maintenance Therapy After First Line Treatment in Locally Advanced or Metastatic Gastric Cancer | unknown | Phase 3 | 40 | The Affiliated Hospital of the Chinese Academy of Military Medical SciencesOTHER | 1 | Aug 2, 2016 | clinicaltrials |
| NCT02817425 | A Efficacy and Tolerability Study of TEGAFOX Sequential S-1 in the Treatment of Adjuvant Chemotherapy for Gastric Cancer | unknown | Phase 2 / Phase 3 | 300 | LanZhou UniversityOTHER | 1 | Jun 29, 2016 | clinicaltrials |
Data updated 22 days agoSource updated Feb 28, 2024source: clinicaltrials